Eli Lilly has also made significant contributions to the insulin pens market. The company’s commitment to digital health is evident in its smart insulin pen initiatives. Meanwhile, companies like ...

The global Insulin Delivery Device Market, valued at US$32.6 billion in 2024 stood at US$35.3 billion in 2025 and is ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Smart insulin pens are expected to drive the insulin pen market from $13.8 billion in 2020 to more than $16 billion by 2030, according to GlobalData. Image. Phil Taylor. 8 November, 2022.

DELRAY BEACH, Fla., June 25, 2025 /PRNewswire/ -- The global Insulin Delivery Device Market, valued at US$32.6 billion in 2024 stood at US$35.3 billion in 2025 and is projected to advance at ...

The market is driven by rising diabetes prevalence worldwide and increasing adoption of wearable and connected devices ...

The Diabetes Devices Market was valued at US$ 33.4 Billion in 2024 and is projected to reach US$ 64.8 Billion by 2033, growing at a CAGR of 7.7%. The U.S. diabetes devices market is witnessing strong ...

Danish pharma giant Novo Nordisk’s announcement comes months after the launch of another top selling obesity drug Mounjaro in India by US based pharma giant Eli Lilly & Company.

Note, however, that Part B does cover the insulin you need to use with the pump, but it doesn’t cover insulin pens or supplies related to insulin, such as syringes, needles, alcohol swabs, or gauze.

According to the company, the Bigfoot Unity reimagines treatment for people with diabetes with a holistic solution featuring first-of-its-kind smart insulin pen caps delivering on-demand dose ...